A 12-week open-label followed by 4-week double-blind study to determine the safety and efficacy of an extended course of alefacept (LFA-3/igg1 fusion protein) in subjects with chronic plaque psoriasis

✍ Scribed by Carin H. Gribetz; Robin Blum; Steven Cohen; Mark Lebwohl

• Book ID: 116578943
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 57 KB
• Volume: 50
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2003.10.490